ArticleFrontiers in pharmacology2026
Gypenoside XLIX ameliorates diabetic retinopathy by downregulating prostaglandin-endoperoxide synthase 2 in retinal pigment epithelium cells to inhibit ferroptosis and preserve tight junction integrity.
Jiayi Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.